Found: 9
Select item for more details and to access through your institution.
Navigating Time and Uncertainty in Health Technology Appraisal: Would a Map Help?
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 9, p. 731, doi. 10.1007/s40273-013-0077-y
- By:
- Publication type:
- Article
Protease Inhibitors for Hepatitis C: Economic Implications.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 9, p. 739, doi. 10.1007/s40273-013-0073-2
- By:
- Publication type:
- Article
The Economic Burden of Toxicities Associated with Cancer Treatment: Review of the Literature and Analysis of Nausea and Vomiting, Diarrhoea, Oral Mucositis and Fatigue.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 9, p. 753, doi. 10.1007/s40273-013-0081-2
- By:
- Publication type:
- Article
Smoking Cessation Treatment and Outcomes Patterns Simulation: A New Framework for Evaluating the Potential Health and Economic Impact of Smoking Cessation Interventions.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 9, p. 767, doi. 10.1007/s40273-013-0070-5
- By:
- Publication type:
- Article
Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 9, p. 781, doi. 10.1007/s40273-013-0074-1
- By:
- Publication type:
- Article
Costs of Parkinson's Disease in a Privately Insured Population.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 9, p. 799, doi. 10.1007/s40273-013-0075-0
- By:
- Publication type:
- Article
Cost-Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 9, p. 807, doi. 10.1007/s40273-013-0076-z
- By:
- Publication type:
- Article
Cost-utility analysis of deferiprone for the treatment of β-thalassaemia patients with chronic iron overload: a UK perspective.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 9, p. 823, doi. 10.1007/s40273-013-0078-x
- By:
- Publication type:
- Article